Valuation dashboard for Milestone Scientific Inc. (MLSS) with P/E N/A, P/B 9.56, EV/EBITDA -9.00 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Milestone Scientific Inc. is dedicated to the innovation, refinement, and global distribution of advanced diagnostic and therapeutic injection technologies and devices. These solutions cater to the medical, dental, and cosmetic industries, with a presence in the United States, China, and other international markets. The company's operations are divided into two main segments: Dental and Medical.
Analysis Summary
Milestone Scientific Inc. reported revenue of $9.0M in the most recent fiscal year, growing at a 5-year CAGR of 10.5%.
Trailing-twelve-month margins: gross margin 69.6%, operating margin -43.6%, net margin -44.0%.
At the current price of $0.40, MLSS has negative trailing earnings (P/E not meaningful) and an ROE of -149.08%. Market capitalisation stands at $35M.
Balance sheet quality for MLSS: current ratio of 1.8. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 9.56 |
| EV / EBITDA | -9.00 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-1.02 |
| vs Current Price | -355.1% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| MLSS | Milestone Scientific Inc. | $35M | 9.56 | -149.1% | |
| 0R29.L | Intuitive Surgical, Inc. | $135.9B | 74.05 | 11.86 | 17.8% |
| ISRG | Intuitive Surgical, Inc. | $135.1B | 44.13 | 7.62 | 17.8% |
| 0R19.L | Becton, Dickinson and Company | $52.5B | 33.21 | 2.19 | 6.6% |
| BDX | Becton, Dickinson and Company | $50.1B | 55.54 | 2.08 | 3.8% |
| RMD | ResMed Inc. | $33.1B | 22.81 | 5.23 | 23.9% |
| 0KW4.L | ResMed Inc. | $32.5B | 19.30 | 4.47 | 23.1% |
| MDLN | Medline Inc. | $27.9B | 38.36 | 2.44 | 5.4% |
Price
| Price | $0.40 |
| Market Cap | $35M |
| Exchange | AMEX |
| Country | US |
Profitability
| Return on Equity | -149.08% |
| Return on Invested Capital | -100.42% |
| Return on Assets | -49.64% |
| Gross Margin | 69.61% |
| Operating Margin | -43.56% |
| Net Margin | -43.98% |
Related companies: APUS · HBIO · IGC · MIRA · MYO · NTRB · NXGL
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of MLSS: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks